Emrusolmin
- Generic Name
- Emrusolmin
- Drug Type
- Small Molecule
- Chemical Formula
- C16H11BrN2O2
- CAS Number
- 882697-00-9
- Unique Ingredient Identifier
- E7WRA77JET
- Background
Emrusolmin restores hippocampal synaptic and transcriptional plasticity as well as spatial memory in a mouse model for Alzheimer's disease, when given orally before or after the onset of pathology.
Mass Balance Clinical Trial With TEV-56286
- First Posted Date
- 2024-10-04
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT06627231
- Locations
- 🇳🇱
Teva Investigational Site 38189, Groningen, Netherlands
A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy (MSA): A Safety and Efficacy Study
- First Posted Date
- 2024-08-23
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06568237
- Locations
- 🇺🇸
Teva Investigational Site 15549, New York, New York, United States
🇺🇸Teva Investigational Site 15554, La Jolla, California, United States
🇺🇸Teva Investigational Site 15547, Washington, District of Columbia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath